Vildagliptin forbedrer alfacellernes følsomhed over for glukose ved at øge de endogene GLP- 1 - niveauer, og det resulterer i mere glukosepassende glucagonsekretion.
By increasing endogenous GLP-1 levels, vildagliptin also enhances the sensitivity of alpha cells to glucose, resulting in more glucose-appropriate glucagon secretion.